Global RSV Diagnostics Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global RSV Diagnostics Market Insights, Forecast to 2034
Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.
Market Analysis and InsightsGlobal RSV Diagnostics Market
Global RSV Diagnostics market is expected to reach to US$ 807.3 million in 2023, with a positive growth of %, compared with US$ 743.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, RSV Diagnostics industry is evaluated to reach US$ 1331 million in 2033. The CAGR will be 8.7% during 2023 to 2033.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Covers
This report presents an overview of global RSV Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global RSV Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Segment by Type
Kits and Assays
Instruments
Other
Hospitals & Clinics
Clinical Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, RSV Diagnostics introduction, etc. RSV Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of RSV Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal RSV Diagnostics Market
Global RSV Diagnostics market is expected to reach to US$ 807.3 million in 2023, with a positive growth of %, compared with US$ 743.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, RSV Diagnostics industry is evaluated to reach US$ 1331 million in 2033. The CAGR will be 8.7% during 2023 to 2033.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Covers
This report presents an overview of global RSV Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global RSV Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Segment by Type
Kits and Assays
Instruments
Other
Segment by Application
Hospitals & Clinics
Clinical Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, RSV Diagnostics introduction, etc. RSV Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of RSV Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch